Exploring Oleoylethanolamide (OEA): A PPAR-Alpha Agonist for Enhanced Satiety
Oleoylethanolamide (OEA), with CAS number 111-58-0, is an endogenous lipid that has emerged as a significant molecule in the field of metabolic health and appetite regulation. Characterized by its high purity (>99%) and white powder form, OEA functions as a potent PPAR-alpha agonist, instrumental in mediating satiety signals and managing energy balance. NINGBO INNO PHARMCHEM CO.,LTD., based in China, is a premier supplier of this compound for scientific research and product development.
The primary role of Oleoylethanolamide is its action as a PPAR-alpha agonist. This receptor is a key regulator of genes involved in lipid metabolism and energy homeostasis. Activation of PPAR-alpha by OEA leads to increased feelings of fullness and reduced food intake, making it a compound of great interest for weight management strategies. The effectiveness of OEA for weight loss is a well-documented area of research, demonstrating its natural ability to curb appetite.
Understanding the specific Oleoylethanolamide properties is crucial for researchers. Its biosynthesis in the intestine following a meal provides a direct link to nutrient sensing and the initiation of satiety signals. This intricate mechanism of endogenous lipid signaling underscores OEA's importance in maintaining metabolic equilibrium.
NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing the scientific community with exceptionally pure Oleoylethanolamide. As a trusted manufacturer, we ensure consistency and quality, which are vital for reproducible research outcomes. Our mission is to support advancements in metabolic health by supplying essential compounds like OEA.
The various Oleoylethanolamide uses extend to its potential as a building block for new pharmaceuticals and dietary supplements targeting appetite control and metabolic disorders. By harnessing the power of OEA, formulators can create products that promote healthier eating habits and support overall well-being. Partner with NINGBO INNO PHARMCHEM CO.,LTD. for your Oleoylethanolamide supply and contribute to the future of metabolic health innovation.
The primary role of Oleoylethanolamide is its action as a PPAR-alpha agonist. This receptor is a key regulator of genes involved in lipid metabolism and energy homeostasis. Activation of PPAR-alpha by OEA leads to increased feelings of fullness and reduced food intake, making it a compound of great interest for weight management strategies. The effectiveness of OEA for weight loss is a well-documented area of research, demonstrating its natural ability to curb appetite.
Understanding the specific Oleoylethanolamide properties is crucial for researchers. Its biosynthesis in the intestine following a meal provides a direct link to nutrient sensing and the initiation of satiety signals. This intricate mechanism of endogenous lipid signaling underscores OEA's importance in maintaining metabolic equilibrium.
NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing the scientific community with exceptionally pure Oleoylethanolamide. As a trusted manufacturer, we ensure consistency and quality, which are vital for reproducible research outcomes. Our mission is to support advancements in metabolic health by supplying essential compounds like OEA.
The various Oleoylethanolamide uses extend to its potential as a building block for new pharmaceuticals and dietary supplements targeting appetite control and metabolic disorders. By harnessing the power of OEA, formulators can create products that promote healthier eating habits and support overall well-being. Partner with NINGBO INNO PHARMCHEM CO.,LTD. for your Oleoylethanolamide supply and contribute to the future of metabolic health innovation.
Perspectives & Insights
Logic Thinker AI
“is committed to providing the scientific community with exceptionally pure Oleoylethanolamide.”
Molecule Spark 2025
“As a trusted manufacturer, we ensure consistency and quality, which are vital for reproducible research outcomes.”
Alpha Pioneer 01
“Our mission is to support advancements in metabolic health by supplying essential compounds like OEA.”